These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2887250)

  • 1. An endogenous ligand of the brain sigma/PCP receptor antagonizes NMDA-induced neurotransmitter release.
    Zukin SR; Zukin RS; Vale W; Rivier J; Nichtenhauser R; Snell LD; Johnson KM
    Brain Res; 1987 Jul; 416(1):84-9. PubMed ID: 2887250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phencyclidine (PCP)-like inhibition of N-methyl-D-aspartate-evoked striatal acetylcholine release, H-TCP binding and synaptosomal dopamine uptake by metaphit, a proposed PCP receptor acylator.
    Snell LD; Johnson KM; Yi SJ; Lessor RA; Rice KC; Jacobson AE
    Life Sci; 1987 Dec; 41(24):2645-54. PubMed ID: 2826948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
    Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization of rat brain phencyclidine receptors in an active binding form that is sensitive to N-methyl-D-aspartate receptor ligands.
    Ambar I; Kloog Y; Sokolovsky M
    J Neurochem; 1988 Jul; 51(1):133-40. PubMed ID: 2898002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage between phencyclidine (PCP) and N-methyl-D-aspartate (NMDA) receptors in the cerebellum.
    Yi SJ; Snell LD; Johnson KM
    Brain Res; 1988 Mar; 445(1):147-51. PubMed ID: 2835121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior.
    Snell LD; Johnson KM
    J Pharmacol Exp Ther; 1985 Oct; 235(1):50-7. PubMed ID: 2864436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex.
    Loo PS; Braunwalder AF; Lehmann J; Williams M; Sills MA
    Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of N-methyl-D-aspartate (NMDA) evoked increases in cerebellar cGMP and striatal ACh release by phencyclidine (PCP) receptor agonists: evidence for possible allosteric coupling of NMDA and PCP receptors.
    Wood PL; Steel D; McPherson SE; Cheney DL; Lehmann J
    Can J Physiol Pharmacol; 1987 Sep; 65(9):1923-7. PubMed ID: 2825947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of brain NMDA receptors: common mechanism of sigma/PCP receptors and their exogenous and endogenous ligands.
    Sircar R; Samaan H; Nichtenhauser R; Snell LD; Johnson KM; Rivier J; Vale W; Zukin RS; Zukin SR
    NIDA Res Monogr; 1986; 75():157-60. PubMed ID: 2828962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate/phencyclidine receptor complex of rat forebrain: purification and biochemical characterization.
    Ikin AF; Kloog Y; Sokolovsky M
    Biochemistry; 1990 Mar; 29(9):2290-5. PubMed ID: 2159797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.
    Rothman RB; Reid AA; Monn JA; Jacobson AE; Rice KC
    Mol Pharmacol; 1989 Dec; 36(6):887-96. PubMed ID: 2557536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phencyclidine and related compounds evoked [3H]dopamine release from rat mesencephalic cell cultures by a mechanism independent of the phencyclidine receptor, sigma binding site, or dopamine uptake site.
    Mount H; Boksa P; Chaudieu I; Quirion R
    Can J Physiol Pharmacol; 1990 Sep; 68(9):1200-6. PubMed ID: 1980428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
    Largent BL; Gundlach AL; Snyder SH
    J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of cortical and hippocampal NMDA and PCP receptors following selective cortical and subcortical lesions.
    Maragos WF; Greenamyre JT; Chu DC; Penney JB; Young AB
    Brain Res; 1991 Jan; 538(1):36-45. PubMed ID: 1850317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A radiohistochemical measure of [3H]TCP binding to the activated NMDA-receptor-gated ion channel in rat brain.
    Hosford DA; Bonhaus DW; McNamara JO
    Brain Res; 1990 May; 516(2):192-200. PubMed ID: 1694710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo.
    Snell LD; Mueller ZL; Gannon RL; Silverman PB; Johnson KM
    J Pharmacol Exp Ther; 1984 Nov; 231(2):261-9. PubMed ID: 6092611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPTP lesions of the nigrostriatal dopaminergic projection decrease [3H]1-[1-(2-thienyl)cyclohexyl]piperidine binding to PCP site 2: further evidence that PCP site 2 is associated with the biogenic amine reuptake complex.
    Akunne HC; Johannessen JN; de Costa BR; Rice KC; Rothman RB
    Neurochem Res; 1992 Mar; 17(3):261-4. PubMed ID: 1320214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting neurochemical interactions of tiletamine, a potent phencyclidine (PCP) receptor ligand, with the N-methyl-D-aspartate-coupled and -uncoupled PCP recognition sites.
    Rao TS; Contreras PC; Cler JA; Mick SJ; Dilworth VM; Iyengar S; Monahan JB; Wood PL
    J Neurochem; 1991 Mar; 56(3):890-7. PubMed ID: 1847186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor.
    Sircar R; Rappaport M; Nichtenhauser R; Zukin SR
    Brain Res; 1987 Dec; 435(1-2):235-40. PubMed ID: 2827853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.